- Home
- Labeler Index
- Hospira, Inc.
- 61703-325
- NDC Crossover: 61703-325 Pamidronate Disodium
NDC Crossover 61703-325 Pamidronate Disodium
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Pamidronate Disodium
The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.
Explore similar products to 61703-325 – Pamidronate Disodium, a human prescription drug. This list includes other cross-matching products that share:
- The same product name: Pamidronate Disodium
- OR Generic name: Pamidronate Disodium
- AND the same Administration Route: intravenous
- OR Dosage Form: injection, solution
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
|---|---|---|---|---|---|---|
| 61703-324 | Pamidronate Disodium | Pamidronate Disodium | Injection, Solution | Intravenous | Hospira, Inc. | Human Prescription Drug |
| 61703-326 | Pamidronate Disodium | Pamidronate Disodium | Injection, Solution | Intravenous | Hospira, Inc. | Human Prescription Drug |
| 67457-430 | Pamidronate Disodium | Pamidronate Disodium | Injection | Intravenous | Mylan Institutional Llc | Human Prescription Drug |
| 67457-446 | Pamidronate Disodium | Pamidronate Disodium | Injection | Intravenous | Mylan Institutional Llc | Human Prescription Drug |